Senior insider sale
SVP, Chief Technical Officer at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$7.2K
2.87K shares
What this filing means
BENESKI BENJAMIN MACHINAS plans to sell 2.87K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $7.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/1/2026ACC: 0002057918-26-000005
Officer· SVP, Chief Technical Officer
Since Mar 2026
2.87K
Shares to sell
$7.2K
Approx. market value
2.87K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
3/31/2026
2.87KTotal acquired2.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 2.87K | — |
| Total | 2.87K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.87K
Market value
$7.2K
4/1/2026
Total
Units
2.87K
Value
$7.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/1/2026 | 2.87K | $7.2K | NASDAQ | Planned |
| Total | 2.87K | $7.2K | ||